Not so secret: agency captives
Although agency captives are by no means new, the encouragement of US domestic domiciles through new legislation in recent years has brought them into greater focus as agents realise the potential to become a stronger player in the market. US Captive has the details.
The trials and tribulations of 831(b)s
Against a backdrop of legal battles and regulatory changes, small captives have been through a lot. But how much has the landscape changed, and are 831(b)s still an attractive option for the middle market? US Captive investigates.
Medical stop loss captives on the rise
Against a backdrop of rising costs in the commercial health insurance market, companies across the US are increasingly looking to self-fund their employee health insurance plans through medical stop loss captives. US Captive finds out how much the sector is growing.
Cannabis captives - hashing out the future
As the cannabis industry in the US continues to grow, its insurance needs grow with it. Inadequacies of the commercial market and complex coverage needs present a prime opportunity for captives to step in, so what does the future hold? US Captive investigates.
Fuelling innovation
Dan Towle reflects on his first year as president of CICA, his outlook on the market and the importance of continuing to fuel innovation in the captives sector.
A new breed of captives
US tax reform provisions have created a substantial tax burden for US insurers conducting business in offshore jurisdictions. Vermont has stepped in with new captive legislation that aims to provide a more favourable onshore alternative, Sandy Bigglestone, director of captive insurance, Vermont Department of Financial Regulation, tells Captive International.
Sweetening the deal? A captive’s value in the context of M&A
Captives can provide value to their affiliated groups and be an intrinsic part of business owners’ exit strategy calculus—or just as easily a burden, says Matthew Queen of Venture Captive Management.
Medical stop loss for single parent captives
As medical costs continue to rise and regulatory uncertainties threaten the amount of control employers are able to maintain within more conventional insurance structures, interest in self-funding and medical stop loss captives will continue to grow, says Phillip Giles of QBE North America.
Reserve Mechanical and the war on small captives
Much like Avrahami, the Reserve Mechanical case is another notch on the IRS’s belt as it continues on its warpath against small captives, hurting the legitimate structures in the process. But what went wrong? Matthew Queen of Venture Captive Management breaks it down.
When the captive fits: the healthcare and employee benefits marketplace
Medical polices within global captive programmes are becoming increasingly popular. Matthias Helmbold, head of technical and services at MAXIS GBN, has the details on market scalability and challenges in the healthcare and employee benefits captives marketplace.
